Login
Barrier Reverse Convertible
Symbol:
RAFAAV
ISIN:
CH1483495342
Issuer:
Bank Vontobel
SIX Structured Products trading
| SIX Structured Products | Bid | Ask | Notation | |
|---|---|---|---|---|
|
Price
30.01.26
22:05:03 |
|
- %
|
- %
|
EUR |
| Volume |
0
|
0
|
nominal | |
| Trading hours for this product: 8:00 – 21:45 | ||||
Performance
| Closing prev. day | 73.51 | ||||
| Diff. absolute / % | 0.00 | 0.00% | |||
Determined prices
| Last Price | 77.51 | Volume | 12,000 | |
| Time | 14:51:18 | Date | 22/01/2026 |
More Product Information
| Details | Underlying | Payment profile | Risk Indicator | Information & Tools | Similar Products |
Core Data
| Name | Barrier Reverse Convertible |
| ISIN | CH1483495342 |
| Valor | 148349534 |
| Symbol | RAFAAV |
| Barrier | 27.44 EUR |
| Cap | 45.74 EUR |
| Quotation in percent | Yes |
| Coupon p.a. | 7.25% |
| Coupon Premium | 5.34% |
| Coupon Yield | 1.91% |
| Type | Barrier Reverse Convertibles |
| SVSP Code | 1230 |
| Barrier reached | Yes (Carl Zeiss Meditec AG - 28/01/2026) |
| COSI Product | No |
| Exercise type | American |
| Currency | Euro |
| First Trading Date | 02/12/2025 |
| Date of maturity | 03/12/2026 |
| Last trading day | 26/11/2026 |
| Settlement Type | Path-dependent |
| IRS 871m | Not applicable |
| Currency safeguarded | No |
| Pricing | Clean |
| Issuer | Bank Vontobel |
Key data
| Sideways yield p.a. | - |
| Distance to Cap | -17.4 |
| Distance to Cap in % | -61.40% |
| Is Cap Level reached | No |
| Distance to Barrier | 0.260001 |
| Distance to Barrier in % | 0.94% |
| Is Barrier reached | Yes |
market maker quality Date: 28/01/2026
| Average Spread | - |
| Last Best Bid Price | 65.00 % |
| Last Best Ask Price | - % |
| Last Best Bid Volume | 250,000 |
| Last Best Ask Volume | 0 |
| Average Buy Volume | 0 |
| Average Sell Volume | 0 |
| Average Buy Value | 0 EUR |
| Average Sell Value | 0 EUR |
| Spreads Availability Ratio | 0.00% |
| Quote Availability | 98.25% |
Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.
Your Bookmarks (0)